OmniAb boosts 2026 cash outlook following Eli Lilly deal — See source for full details.
$OABI
Price history, market instrument context, member research, and related headlines in one place.
OABI key statistics
NasdaqGMUSD
52-week range
$1.3081%$5.43
Latest session $4.52–$4.79OmniAb, Inc. (OABI) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $4.66, down $0.12 (2.51%) from the previous close of $4.78. It has traded between $4.52 and $4.79 in the latest session. Over the past year it has ranged from $1.30 to $5.43, leaving it in the upper quarter of its 52-week range (81%). Reported volume for the session was 1.3M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
WOOK AIASK ANYTHING · NEVER ADVISES
Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.
Source-linked intelligence
Related news
OmniAb raises 2026 cash guidance on licensing activity — See source for full details.
OmniAb signs up to $370M licensing deal with Eli Lilly for ion channel program — See source for full details.
OmniAb GAAP EPS of -$0.05 beats by $0.07, revenue of $13.4M beats by $8.71M — See source for full details.
OmniAb Q2 2026 slides: revenue surges on milestones, guidance raised — See source for full details.
Loading $OABI research…